Browse Category

NASDAQ:STLD News 6 January 2026

BlueScope Steel stock jumps 21% on A$30 takeover bid — the next catalyst investors are watching

BlueScope Steel stock jumps 21% on A$30 takeover bid — the next catalyst investors are watching

SYDNEY, Jan 6, 2026, 16:58 AEDT — Market closed BlueScope Steel Limited (ASX:BSL) shares closed up 20.57% at A$29.48 on Tuesday after Australian conglomerate SGH and U.S. steelmaker Steel Dynamics confirmed an approach to buy the company for A$30 a share in cash. Investing The move pulled the stock to within about 1.7% of the indicative price, leaving traders to…

Stock Market Today

  • Clarity Pharmaceuticals Shares Fall as Individual Investors Face Losses
    January 30, 2026, 7:43 PM EST. Clarity Pharmaceuticals Ltd (ASX:CU6) saw its market cap drop by AU$145 million last week after an 11% share price fall. Individual investors hold 48% of the stock, making them the most affected by the decline. Institutional investors, owning 24%, also incurred losses. The top 18 shareholders collectively own 51%, with insiders holding 13%. Hedge funds, including Regal Partners Limited as the largest shareholder with 6.1%, play an active role in the stock's dynamics. Institutional interest implies some professional confidence but does not guarantee performance. Market watchers advise considering analyst forecasts alongside ownership data for a fuller picture of Clarity Pharmaceuticals' outlook.
Go toTop